Business
Currency:USD
2024/FY
Stock NameRevenueRatio
Other products145.03M19.81%
BAQSIMI126.9M17.34%
Glucagon108.32M14.80%
Primatene MIST102.01M13.94%
Epinephrine94.09M12.85%
Lidocaine55.85M7.63%
Phytonadione43.17M5.90%
Enoxaparin21.72M2.97%
Other revenues19.15M2.62%
Other15.73M2.15%
View all
Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States707.68M96.68%
France19.95M2.73%
China4.34M0.59%